Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in ER+HER2-Negative Breast Cancer in Postmenopausal Patients: Preliminary Results of a Single-Center Matched-Cohort Study. Voprosy onkologii, v. 71, n. 3, p. OF-2304, 30 Jun.2025.